TrovaGene, Inc. (TROV) - Product Pipeline Analysis, 2016 Update

Date: May 25, 2016
Pages: 48
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T673DA1068BEN
Leaflet:

Download PDF Leaflet

TrovaGene, Inc. (TROV) - Product Pipeline Analysis, 2016 Update
Summary

TrovaGene, Inc. (TrovaGene), is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary diagnostic technologies for screening and monitoring of various diseases. The company’s proprietary urine-based molecular diagnostic tests are used in detection of transrenal DNA (TrDNA) and RNA (TrRNA). The technology is used in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in clinical trials. It out-licenses its transrenal technologies to extend oncogene mutation detection using urine as a sample. The company has worldwide rights to worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myelogenous leukemia (AML) and mutations in the SF3B1 gene. TrovaGene is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company TrovaGene, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
TrovaGene, Inc. Company Snapshot
TrovaGene, Inc. Company Overview
TrovaGene, Inc. Pipeline Products and Clinical Trials Overview
TrovaGene, Inc. – Pipeline Analysis Overview
Business Description
Key Facts
TrovaGene, Inc. - Major Products and Services
TrovaGene, Inc. Pipeline Products by Development Stage
TrovaGene, Inc. Pipeline Products Overview
Anti-TNF Panel Assay
Anti-TNF Panel Assay Product Overview
Cell-free DNA Mutation Assay
Cell-free DNA Mutation Assay Product Overview
Diagnostic Assay - Chronic Lymphocytic Leukemia
Diagnostic Assay - Chronic Lymphocytic Leukemia Product Overview
Diagnostic Assay - HBV
Diagnostic Assay - HBV Product Overview
Diagnostic Assay - Lyme Disease
Diagnostic Assay - Lyme Disease Product Overview
Diagnostic Assay - p53
Diagnostic Assay - p53 Product Overview
Diagnostic Assay - PIK3CA
Diagnostic Assay - PIK3CA Product Overview
Diagnostic Test - JC Virus
Diagnostic Test - JC Virus Product Overview
Diagnostic Test - Liver Cancer
Diagnostic Test - Liver Cancer Product Overview
EBV Diagnostic Assay
EBV Diagnostic Assay Product Overview
EGFR Mutation Detection Test - Lung Cancer
EGFR Mutation Detection Test - Lung Cancer Product Overview
HIV Tr-DNA Genotype Test
HIV Tr-DNA Genotype Test Product Overview
HPV Diagnostic Test - Men
HPV Diagnostic Test - Men Product Overview
miRNA Test - Alzheimer's Disease
miRNA Test - Alzheimer's Disease Product Overview
miRNA Test - Brain Stroke
miRNA Test - Brain Stroke Product Overview
miRNA Test - Kidney Transplantation
miRNA Test - Kidney Transplantation Product Overview
Next Generation CMOS Sensor Detection Platform
Next Generation CMOS Sensor Detection Platform Product Overview
Non Invasive Prenatal Screening Test
Non Invasive Prenatal Screening Test Product Overview
TB Tr-DNA Virulence Test
TB Tr-DNA Virulence Test Product Overview
Tr-DNA based Anthrax assay
Tr-DNA based Anthrax assay Product Overview
Tr-DNA based H. pylori assay
Tr-DNA based H. pylori assay Product Overview
Tr-DNA based HIV proviral DNA assay
Tr-DNA based HIV proviral DNA assay Product Overview
Tr-DNA based Leishmania assay
Tr-DNA based Leishmania assay Product Overview
Tr-DNA Malaria assay
Tr-DNA Malaria assay Product Overview
Tr-DNA Tuberculosis Assay
Tr-DNA Tuberculosis Assay Product Overview
TrovaGene, Inc. - Key Competitors
TrovaGene, Inc. - Key Employees
TrovaGene, Inc. - Key Employee Biographies
TrovaGene, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
TrovaGene, Inc., Recent Developments
May 19, 2016: Large Clinical Data Set in Lung Cancer Featuring Trovagene's Precision Cancer Monitoring Platform Selected for Oral Presentation at the 2016 ASCO Annual Meeting
May 19, 2016: Large Clinical Data Set in Lung Cancer Featuring Trovagene's Precision Cancer Monitoring Platform Selected for Oral Presentation at the 2016 ASCO Annual Meeting
May 13, 2016: Large Clinical Study Demonstrates High Detection Rate and Ability to Monitor KRAS Mutations in Pancreatic Cancer Patients; Results Presented at 2016 AACR Pancreatic Cancer Meeting
May 10, 2016: Trovagene Announces First Quarter 2016 Financial Results
Apr 25, 2016: Trovagene Appoints Bill Welch as Chief Executive Officer
Apr 15, 2016: Patient Case Report Demonstrating the Ability of Trovagene's Precision Cancer Monitoring Platform to Determine Early Drug Response Published in Cancer Discovery
Apr 11, 2016: Trovagene Enters Into Preferred Provider Agreement with Stratose PPO Network
Apr 07, 2016: Clinical Data Featuring Trovagene's Precision Cancer Monitoring Platform to be Presented at the Molecular DX Europe Conference
Mar 28, 2016: Trovagene Terminates the Employment of CEO Antonius Schuh and CFO Stephen Zaniboni for Cause
Mar 24, 2016: Clinical Study Results Featuring Trovagene's Precision Cancer Monitoring Platform to be Presented at the AACR Annual Meeting 2016
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

TrovaGene, Inc. Pipeline Products and Clinical Trials Overview
TrovaGene, Inc. Pipeline Products by Equipment Type
TrovaGene, Inc. Pipeline Products by Indication
TrovaGene, Inc., Key Facts
TrovaGene, Inc., Major Products and Services
TrovaGene, Inc. Number of Pipeline Products by Development Stage
TrovaGene, Inc. Pipeline Products Summary by Development Stage
Anti-TNF Panel Assay - Product Status
Anti-TNF Panel Assay - Product Description
Cell-free DNA Mutation Assay - Product Status
Cell-free DNA Mutation Assay - Product Description
Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
Diagnostic Assay - HBV - Product Status
Diagnostic Assay - HBV - Product Description
Diagnostic Assay - Lyme Disease - Product Status
Diagnostic Assay - Lyme Disease - Product Description
Diagnostic Assay - p53 - Product Status
Diagnostic Assay - p53 - Product Description
Diagnostic Assay - PIK3CA - Product Status
Diagnostic Assay - PIK3CA - Product Description
Diagnostic Test - JC Virus - Product Status
Diagnostic Test - JC Virus - Product Description
Diagnostic Test - Liver Cancer - Product Status
Diagnostic Test - Liver Cancer - Product Description
EBV Diagnostic Assay - Product Status
EBV Diagnostic Assay - Product Description
EGFR Mutation Detection Test - Lung Cancer - Product Status
EGFR Mutation Detection Test - Lung Cancer - Product Description
HIV Tr-DNA Genotype Test - Product Status
HIV Tr-DNA Genotype Test - Product Description
HPV Diagnostic Test - Men - Product Status
HPV Diagnostic Test - Men - Product Description
miRNA Test - Alzheimer's Disease - Product Status
miRNA Test - Alzheimer's Disease - Product Description
miRNA Test - Brain Stroke - Product Status
miRNA Test - Brain Stroke - Product Description
miRNA Test - Kidney Transplantation - Product Status
miRNA Test - Kidney Transplantation - Product Description
Next Generation CMOS Sensor Detection Platform - Product Status
Next Generation CMOS Sensor Detection Platform - Product Description
Non Invasive Prenatal Screening Test - Product Status
Non Invasive Prenatal Screening Test - Product Description
TB Tr-DNA Virulence Test - Product Status
TB Tr-DNA Virulence Test - Product Description
Tr-DNA based Anthrax assay - Product Status
Tr-DNA based Anthrax assay - Product Description
Tr-DNA based H. pylori assay - Product Status
Tr-DNA based H. pylori assay - Product Description
Tr-DNA based HIV proviral DNA assay - Product Status
Tr-DNA based HIV proviral DNA assay - Product Description
Tr-DNA based Leishmania assay - Product Status
Tr-DNA based Leishmania assay - Product Description
Tr-DNA Malaria assay - Product Status
Tr-DNA Malaria assay - Product Description
Tr-DNA Tuberculosis Assay - Product Status
Tr-DNA Tuberculosis Assay - Product Description
TrovaGene, Inc., Key Employees
TrovaGene, Inc., Key Employee Biographies
TrovaGene, Inc., Other Locations

LIST OF FIGURES

TrovaGene, Inc. Pipeline Products by Equipment Type
TrovaGene, Inc. Pipeline Products by Development Stage

COMPANIES MENTIONED

Qiagen N.V.
Exact Sciences Corporation
Boreal Genomics Inc.
Sysmex Inostics Inc.
Sequenom, Inc.
Illumina, Inc.
Genomic Health, Inc.
Cepheid
Skip to top


Ask Your Question

TrovaGene, Inc. (TROV) - Product Pipeline Analysis, 2016 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: